Skip to content

PTHS PTHS Accounts Payable

Accounts Payable at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$16.54M+18.7%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$8.2M-43.1%
Opko Health logo
Opko HealthOPK
$44.18M-25.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$11.69M-34.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1.1M-54.3%
HRO
HarrowHROW
$26.13M-29.6%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's accounts payable?
PTHS (PTHS) reported accounts payable of $6.15M in Q1 2026.
How has PTHS's accounts payable changed year-over-year?
PTHS's accounts payable increased by 136.1% year-over-year, from $2.6M to $6.15M.
What is the long-term trend for PTHS's accounts payable?
Over 3 years (2022 to 2025), PTHS's accounts payable has grown at a -0.1% compound annual growth rate (CAGR), from $2.99M to $2.99M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.